Usefulness of osteoprotegerin in assessing responses to neridronate treatment in Paget's disease of bone

Osteoprotegerin (OPG) is a protein that inhibits of osteoclastogenesis. The aim this study was to evaluate the response of serum OPG levels to neridronate treatment in patients with Paget's disease of bone resistant to previous therapy. Nine patients (4 men) affected by active Paget’s disease o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulivieri, F. M., Piodi, L. P., Marotta, G., Marchelli, D., Commadini, C., Parravicini, L., Verdoia, C., Gerundini, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2006
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901208/
http://dx.doi.org/10.1007/s10195-006-0147-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901208/
http://dx.doi.org/10.1007/s10195-006-0147-4

Ejemplares similares